hrp0086p1-p211 | Diabetes P1 | ESPE2016
Heinrich Michaela , Galler Angela
hrp0095fc7.2 | Growth and Syndromes | ESPE2022
Phillip Moshe , Deal Cheri , Silverman Lawrence , Henocque Robin , Nijher Monica , Wajnrajch Michael , Wang Ronnie , Cara Jose
hrp0095fc10.2 | GH and IGFs | ESPE2022
Garner Terence , Clayton Peter , Murray Philip , Bagci Ekaterine , Højby Michael , Stevens Adam
hrp0095rfc7.1 | Growth and Syndromes | ESPE2022
German Alina , Albertsson-Wikland Kerstin , Shmoish Michael , Rubin Lisa , Niklasson Aimon , Hochberg Ze'ev
hrp0095t7 | Section | ESPE2022
Deal Cheri , Silverman Lawrence , Korth-Bradley Joan , Roland Carl , Taylor Carrie , Cara Jose , Wajnrajch Michael
hrp0095p1-64 | Fat, Metabolism and Obesity | ESPE2022
Roos Julian , Wu Hang , Pula Taner , Tews Daniel , Wabitsch Martin , Debatin Klaus-Michael , Fischer-Posovszky Pamela
hrp0095p1-462 | Fat, Metabolism and Obesity | ESPE2022
Hochberg Ze'ev , Albertsson-Wikland Kerstin , Privé Florian , Holmgren Anton , Rubin Lisa , German Alina , Shmoish Michael
hrp0095p1-119 | Growth and Syndromes | ESPE2022
Gomez Roy , Khadilkar Vaman , Shembalkar Jayashri , Chu Der-Ming , Woo Ko Cheol , Wajnrajch Michael , Wang Ronnie
hrp0095p1-328 | Growth and Syndromes | ESPE2022
Loftus Jane , Wogen Jenifer , Benjumea Darrin , Jhingran Priti , Chen Yong , Alvir Jose , Wajnrajch Michael
hrp0095p1-108 | Growth and Syndromes | ESPE2022
Efficacy, Observer-Reported Outcomes, and Safety of Once-Weekly Somapacitan in Children with Growth Hormone Deficiency (GHD): 4-Year Results from the REAL 3 Trial
Sävendahl Lars , Battelino Tadej , Højby Rasmussen Michael , Brod Meryl , Wai Lee Kai , Saenger Paul , Horikawa Reiko